{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:41:49Z","timestamp":1791286909745,"version":"4.1.0"},"reference-count":53,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T00:00:00Z","timestamp":1402358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1034642"],"award-info":[{"award-number":["1034642"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["British J Pharmacology"],"published-print":{"date-parts":[[2014,7]]},"abstract":"<jats:sec><jats:title>Background and Purpose<\/jats:title><jats:p>\u03c9\u2010Conotoxins <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">CVIF<\/jats:styled-content> (<jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>) selectively inhibit <jats:styled-content style=\"fixed-case\">Ca<jats:sub>v<\/jats:sub><\/jats:styled-content>2.2 channels and are lead molecules in the development of novel analgesics. At physiological membrane potentials, <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> block of <jats:styled-content style=\"fixed-case\">Ca<jats:sub>v<\/jats:sub><\/jats:styled-content>2.2 channels is weakly reversible. To improve reversibility, we designed and synthesized arginine <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> analogues in which arginine was substituted for lysine at position 10 ([<jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content>]<jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>), and investigated their serum stability and pharmacological actions on voltage\u2010gated calcium channels (<jats:styled-content style=\"fixed-case\">VGCCs<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Experimental Approach<\/jats:title><jats:p>Changes in peptide structure due to <jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content> substitution were assessed by <jats:styled-content style=\"fixed-case\">NMR<\/jats:styled-content>. Peptide stability in human serum was analysed by reversed\u2010phase <jats:styled-content style=\"fixed-case\">HPLC<\/jats:styled-content> and <jats:styled-content style=\"fixed-case\">MS<\/jats:styled-content> over a 24\u2009h period. Two\u2010electrode voltage\u2010clamp and whole\u2010cell patch clamp techniques were used to study [<jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content>]<jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> effects on <jats:styled-content style=\"fixed-case\">VGCC<\/jats:styled-content> currents in <jats:styled-content style=\"fixed-case\"><jats:italic>X<\/jats:italic><\/jats:styled-content><jats:italic>enopus<\/jats:italic> oocytes and rat dorsal root ganglion neurons respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key Results<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content> substitution did not change the conserved \u03c9\u2010conotoxin backbone conformations of <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> nor the \u03c9\u2010conotoxin selectivity for recombinant or native <jats:styled-content style=\"fixed-case\">Ca<jats:sub>v<\/jats:sub><\/jats:styled-content>2.2 channels, although the inhibitory potency of [<jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content>]<jats:styled-content style=\"fixed-case\">CVIF<\/jats:styled-content> was better than that of <jats:styled-content style=\"fixed-case\">CVIF<\/jats:styled-content>. At \u221280\u2009mV, the <jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content> chemical modification significantly affected \u03c9\u2010conotoxin\u2212channel interaction, resulting in faster onset kinetics than those of <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>. Heterologous and native <jats:styled-content style=\"fixed-case\">Ca<jats:sub>v<\/jats:sub><\/jats:styled-content>2.2 channels recovered better from [<jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content>]<jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> block than <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content>. In human serum, the \u03c9\u2010conotoxin half\u2010lives were 6\u221210\u2009h. <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> and [<jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content>]<jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> were more stable than <jats:styled-content style=\"fixed-case\">CVID<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions and Implications<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">R10K<\/jats:styled-content> substitution in <jats:styled-content style=\"fixed-case\">CVIE<\/jats:styled-content>&amp;<jats:styled-content style=\"fixed-case\">F<\/jats:styled-content> significantly alters the kinetics of \u03c9\u2010conotoxin action and improves reversibility without diminishing conotoxin potency and specificity for the <jats:styled-content style=\"fixed-case\">Ca<jats:sub>v<\/jats:sub><\/jats:styled-content>2.2 channel and without diminishing the serum stability. These results may help generate \u03c9\u2010conotoxins with optimized kinetic profiles for target binding.<\/jats:p><\/jats:sec>","DOI":"10.1111\/bph.12686","type":"journal-article","created":{"date-parts":[[2014,3,14]],"date-time":"2014-03-14T04:10:45Z","timestamp":1394770245000},"page":"3313-3327","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Effects of arginine 10 to lysine substitution on \u03c9\u2010conotoxin <scp>CVIE<\/scp> and <scp>CVIF<\/scp> block of <scp>Ca<sub>v<\/sub><\/scp>2.2 channels"],"prefix":"10.1111","volume":"171","author":[{"given":"G","family":"Berecki","sequence":"first","affiliation":[{"name":"Health Innovations Research Institute RMIT University  Melbourne Vic Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N L","family":"Daly","sequence":"additional","affiliation":[{"name":"Division of Chemistry and Structural Biology Institute for Molecular Bioscience The University of Queensland  Brisbane Qld Australia"},{"name":"Centre for Biodiscovery and Molecular Development of Therapeutics School of Pharmacy and Molecular Sciences James Cook University  Cairns Qld Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y H","family":"Huang","sequence":"additional","affiliation":[{"name":"Division of Chemistry and Structural Biology Institute for Molecular Bioscience The University of Queensland  Brisbane Qld Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Vink","sequence":"additional","affiliation":[{"name":"Division of Chemistry and Structural Biology Institute for Molecular Bioscience The University of Queensland  Brisbane Qld Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Craik","sequence":"additional","affiliation":[{"name":"Division of Chemistry and Structural Biology Institute for Molecular Bioscience The University of Queensland  Brisbane Qld Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P F","family":"Alewood","sequence":"additional","affiliation":[{"name":"Division of Chemistry and Structural Biology Institute for Molecular Bioscience The University of Queensland  Brisbane Qld Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D J","family":"Adams","sequence":"additional","affiliation":[{"name":"Health Innovations Research Institute RMIT University  Melbourne Vic Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2014,6,10]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209969200"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2011.01781.x"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12447"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2004.07.004"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.1.5.439"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi992651h"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0700865"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.109.058834"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2009.09.021"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/ars.2007.1856"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3594-08.2008"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a003947"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.57.4.5"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.54.2.323"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/anie.201000620"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1021\/cb700091j"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0041-0101(00)00160-4"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.342998"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200108080-00027"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1472-8206.2009.00801.x"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12251"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00872.x"},{"key":"e_1_2_8_24_1","doi-asserted-by":"crossref","first-page":"23876","DOI":"10.1016\/S0021-9258(19)51019-5","article-title":"Hydroxyl group of Tyr13 is essential for the activity of \u03c9\u2010conotoxin GVIA, a peptide toxin for N\u2010type calcium channel","volume":"269","author":"Kim JI","year":"1994","journal-title":"J Biol Chem"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/0263-7855(96)00009-4"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M002252200"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.111.005322"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.310110"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6446(05)03662-7"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.00873.x"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.2174\/0929867043363884"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1460-9568.2006.05299.x"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310848200"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-9781(00)00175-3"},{"key":"e_1_2_8_35_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi982980u"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.63.070194.004135"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1186\/1744-8069-9-51"},{"key":"e_1_2_8_38_1","first-page":"151","article-title":"Novel \u03c9\u2010conotoxins potently inhibit N\u2010type voltage\u2010gated calcium channels in sensory neurons and partially reverse pain behavior after systemic dosing","volume":"23","author":"Sadeghi M","year":"2013","journal-title":"Proc Aust Neurosci Soc"},{"key":"e_1_2_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60354-6"},{"key":"e_1_2_8_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3011.1992.tb00291.x"},{"key":"e_1_2_8_41_1","doi-asserted-by":"publisher","DOI":"10.2174\/157340606778250216"},{"key":"e_1_2_8_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02247-1"},{"key":"e_1_2_8_43_1","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1992.sp018944"},{"key":"e_1_2_8_44_1","doi-asserted-by":"publisher","DOI":"10.1602\/neurorx.2.4.662"},{"key":"e_1_2_8_45_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.17-09-03002.1997"},{"key":"e_1_2_8_46_1","first-page":"31","article-title":"The role of binding kinetics in therapeutically useful drug action","volume":"12","author":"Swinney DC","year":"2009","journal-title":"Current Opin Drug Discov Devel"},{"key":"e_1_2_8_47_1","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00020.2003"},{"key":"e_1_2_8_48_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2012.02082.x"},{"key":"e_1_2_8_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/AJP.0b013e3181e017df"},{"key":"e_1_2_8_50_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270003253349"},{"key":"e_1_2_8_51_1","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.9.9.1575"},{"key":"e_1_2_8_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00227471"},{"key":"e_1_2_8_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1403.2012.00479.x"},{"key":"e_1_2_8_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresrev.2008.12.021"}],"container-title":["British Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbph.12686","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bph.12686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:45:54Z","timestamp":1696290354000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bph.12686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,10]]},"references-count":53,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1111\/bph.12686"],"URL":"https:\/\/doi.org\/10.1111\/bph.12686","archive":["Portico"],"relation":{},"ISSN":["0007-1188","1476-5381"],"issn-type":[{"value":"0007-1188","type":"print"},{"value":"1476-5381","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,10]]},"assertion":[{"value":"2013-11-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-03-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-06-10","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}